The study’s authors examined data from more than 15,000 patients who had their first intracerebral hemorrhage from January 2003 to December 2021

Researchers uncovered new details about how mitral regurgitation can impact one-year TAVR outcomes, sharing their findings in the Journal of the American Heart Association.

Medicare enrollees paid a total of $3.4 billion in out-of-pocket costs for these drugs in 2022 alone, according to new data shared by the White House. 

New research published in the Canadian Journal of Cardiology represents one the most detailed pictures to date of the long-term impact of ViV TMVR.

Researchers explored data from more than 400 STEMI patients, presenting their work at ESC Congress 2023 and publishing it in the New England Journal of Medicine.

The latest Class I recall is due to mechanical issues that can cause the devices to stop charging their batteries. 

This is a Class I recall, which means using the devices “may cause serious injuries or death.” The catheter's instructions have been updated to reduce the risk of complications going forward. 

A new study out of Denmark suggests two advanced artificial intelligence algorithms are better than one. 

New research out of Norway focused on 6 common cancer screening tests, tracking their impact on more than 2 million patients.